Russell 2000
2247.16 €
20.78 € | 0.93 %
CBOE VIX Volatility Index
90.84 €
1.04 € | 1.16 %
Treasury Yield 10 Years Index
4.35 €
0.06 € | 1.28 %
NASDAQ 100
22866.97 €
225.08 € | 0.99 %
S&P/ASX 200
8614 €
18.2 € | 0.21 %
CAC 40
7754.55 €
16.13 € | 0.21 %
S&P 500
6277.76 €
50.34 € | 0.81 %
DAX Performance Index
23934.13 €
144.02 € | 0.61 %
Dow Jones
44828.54 €
344.11 € | 0.77 %
Nikkei 225
39779.46 €
-6.44 € | -0.02 %
FTSE 100
8823.2 €
48.51 € | 0.55 %
Hang Seng Index
24069.94 €
-151.47 € | -0.63 %
Top 15 Gainers
Global Interactive Technologies, Inc. (GITS) 1.95€ | 119.63 %
Regencell Bioscience Holdings Limited (RGC) 11.07€ | 106.85 %
La Rosa Holding Corp. Common Stock (LRHC) 0.0689€ | 86.02 %
Inno Holdings Inc. Common Stock (INHD) 0.85€ | 58.22 %
Hashdex Bitcoin Futures ETF (DEFI) 46.15€ | 57.82 %
Enigmatig Limited (EGG) 1.98€ | 53.51 %
Wolfspeed, Inc. (WOLF) 0.4069€ | 52.63 %
Lixte Biotechnology Holdings, Inc. (LIXT) 0.7509€ | 37.17 %
Xponential Fitness, Inc. (XPOF) 2.645€ | 35.48 %
Theratechnologies Inc. (THTX) 0.805€ | 34.11 %
MDB Capital Holdings, LLC Class A common (MDBH) 1.38€ | 32.09 %
ReTo Eco-Solutions, Inc. (RETO) 0.64€ | 30.62 %
Cognition Therapeutics, Inc. (CGTX) 0.0997€ | 29.74 %
Jupiter Neurosciences, Inc. (JUNS) 0.3493€ | 29.35 %
M3-Brigade Acquisition V Corp. Units (MBAVU) 3.8€ | 29.28 %
Top 15 Loosers
Charles & Colvard, Ltd. (CTHR) -0.78€ | -78 %
Inovio Pharmaceuticals, Inc. (INO) -0.78€ | -36.45 %
GIBO Holdings Limited (GIBO) -0.0359€ | -30.27 %
CID HoldCo, Inc. Common Stock (DAIC) -2€ | -24.42 %
Blue Gold Limited Class A Ordinary Shares (BGL) -31.68€ | -23.82 %
Fast Track Group (FTRK) -0.21€ | -22.83 %
Netcapital Inc. (NCPL) -1.89€ | -22.37 %
CBL International Limited (BANL) -0.1819€ | -19.84 %
PodcastOne, Inc. (PODC) -0.54€ | -18.82 %
Flanigan's Enterprises, Inc. (BDL) -5.72€ | -16.47 %
Mogo Inc. (MOGO) -0.41€ | -15.95 %
Epsium Enterprise Limited Ordinary Shares (EPSM) -2.5€ | -15.82 %
Xcel Brands, Inc. (XELB) -0.2997€ | -15.78 %
Mullen Automotive, Inc. (MULN) -0.0432€ | -15.77 %
Jyong Biotech Ltd. Ordinary Shares (MENS) -1.43€ | -14.86 %
Sector Market Performance
Basic Materials -0.18 %
Communication Services 0.07 %
Consumer Cyclical 0.29 %
Consumer Defensive 0.25 %
Energy 0.53 %
Financial Services 0.13 %
Healthcare 0.09 %
Industrials 0.88 %
Real Estate -0.59 %
Technology 1.07 %
Utilities 1.03 %

UiPath Inc. (NYSE:PATH) Overview: Financial Health and Market Position
2025-07-03 19:00:21
- UiPath Inc. (NYSE:PATH) demonstrates financial robustness with significant cash reserves and a conservative debt approach, indicated by a debt-to-equity ratio of 0.043.
- The company's commitment to innovation in the robotic process automation (RPA) sector contributes to high customer retention rates and optimism for future growth.
- Despite negative earnings, UiPath's valuation metrics such as a price-to-sales ratio of 4.9 and enterprise value to sales ratio of 4.47 reflect investor confidence in its sales performance and future prospects.
UiPath Inc. (NYSE:PATH) is a leading company in the field of robotic process automation (RPA). It provides software that helps businesses automate repetitive tasks, improving efficiency and productivity. The company faces competition from other tech firms in the automation space, but it remains a significant player due to its innovative solutions and strong market presence.
On July 3, 2025, Dines Daniel, the director, 10 percent owner, CEO, and Chairman of PATH, sold 45,000 shares of Class A Common Stock at approximately $13.01 each. Despite this sale, Daniel still holds a substantial 5,418,376 shares, indicating his continued confidence in the company's future. This transaction is officially documented on the SEC website.
UiPath is navigating the challenges posed by generative AI, maintaining stability and easing fears of an existential crisis. The company is financially robust, with significant cash reserves and ongoing share repurchases. These factors, along with high customer retention rates, contribute to optimism for renewed growth and sustainable GAAP profitability.
The company's financial metrics provide further insight into its current standing. UiPath's price-to-earnings (P/E) ratio is -108, reflecting negative earnings. However, the price-to-sales ratio of 4.9 and enterprise value to sales ratio of 4.47 suggest that investors see potential in the company's sales performance. The low debt-to-equity ratio of 0.043 indicates a conservative approach to debt.
UiPath's current ratio of 2.95 highlights its strong ability to cover short-term liabilities with short-term assets. Despite a negative earnings yield of -0.93%, the company's enterprise value to operating cash flow ratio of 19.1 shows that investors are willing to pay for its operating cash flow. Management remains optimistic about the company's prospects for fiscal year 2027.

Fastenal Company (NASDAQ:FAST) Earnings and Stock Analysis
2025-07-03 18:00:14
Fastenal Company (NASDAQ:FAST) is a leading entity in the industrial and construction supplies sector, renowned for its comprehensive product lineup, including fasteners, tools, and safety equipment. Competing against industry stalwarts like Grainger and MSC Industrial Direct, Fastenal is on the verge of unveiling its second-quarter earnings on July 14, 2025.
On July 3, 2025, David Manthey from Robert W. Baird established a price target of $86 for FAST, which was trading at $43.13 at that moment. This projection indicates a potential price surge of approximately 99.4%. The forthcoming earnings report from Fastenal is anticipated to reveal earnings of 28 cents per share, an improvement from 25 cents per share in the corresponding period the previous year, signifying positive growth.
Fastenal's expected quarterly revenue is projected to hit $2.07 billion, a rise from $1.92 billion a year earlier. This revenue growth is in harmony with the optimistic price target set by David Manthey. Despite a minor decline of 0.4%, closing at $42.68, the stock has demonstrated resilience with a 1.05% increment, reaching $43.13.
Earlier in the year, Fastenal announced a two-for-one stock split on April 23, aimed at making the stock more accessible to a broader range of investors. Morgan Stanley analyst Chris Snyder maintained an Equal-Weight rating for Fastenal and raised the price target from $38 to $40 on May 23, 2025, reflecting a cautiously optimistic stance.
With a market capitalization of approximately $49.48 billion and a trading volume of 2,955,923 shares, Fastenal's stock has oscillated between a low of $42.625 and a high of $43.5 today, marking its peak price over the past year. The lowest price for the stock in the past year was $31.015, showcasing its upward trajectory.

American Outdoor Brands, Inc. (NASDAQ:AOUT) Under Investigation
2025-07-03 18:00:03
- American Outdoor Brands, Inc. (NASDAQ:AOUT) is being investigated by Pomerantz LLP for potential securities fraud or other unlawful business practices following its Q4 and full fiscal year 2025 financial results.
- The company reported earnings per share of $0.13, surpassing the estimated -$0.02, and revenue of approximately $61.9 million, exceeding the estimated $48.5 million.
- American Outdoor announced the suspension of its fiscal 2026 guidance due to uncertainties surrounding tariffs, leading to a stock price drop of $1.57 per share, or 13.13%, closing at $10.39 on June 27, 2025.
American Outdoor Brands, Inc. (NASDAQ:AOUT) is currently facing an investigation by Pomerantz LLP for potential securities fraud or other unlawful business practices. This investigation was prompted by the company's financial results for the fourth quarter and full fiscal year 2025. American Outdoor, a competitor of Vista Outdoor and Sturm, Ruger & Co., is known for its outdoor products.
The investigation follows a press release where American Outdoor disclosed that retailers had accelerated orders, pulling forward an estimated $8 to $10 million in sales from the upcoming fiscal year. This move has raised concerns about the company's financial practices. Despite these concerns, AOUT reported earnings per share of $0.13, surpassing the estimated -$0.02, as highlighted by the recent financial report.
American Outdoor also announced the suspension of its fiscal 2026 guidance due to uncertainties surrounding tariffs. This uncertainty has impacted investor confidence, leading to a stock price drop of $1.57 per share, or 13.13%, closing at $10.39 on June 27, 2025. However, the company reported revenue of approximately $61.9 million, exceeding the estimated $48.5 million, indicating strong sales performance.
Currently, AOUT's stock price is $10.62, reflecting a 0.76% increase with a change of $0.08. The stock has fluctuated between a low of $10.33 and a high of $10.75 today. Over the past year, AOUT has reached a high of $17.91 and a low of $8.11, showing significant volatility. The company's market capitalization is approximately $135.49 million, with a trading volume of 100,635 shares on the NASDAQ exchange.

UBS Maintains Neutral Rating on Apple Inc. (NASDAQ:AAPL) Amid Growth in China
2025-07-03 16:00:13
- Apple Inc. (NASDAQ:AAPL) sees an 8% year-over-year increase in iPhone sales in China for Q2 2025.
- The growth is attributed to promotional pricing of the iPhone 16 lineup during the 618 shopping festival.
- Despite positive sales growth, Apple's performance was outpaced by Huawei, highlighting the competitive nature of the Chinese market.
On July 3, 2025, UBS reiterated its Neutral rating for Apple Inc. (NASDAQ:AAPL), advising investors to hold the stock. At the time, Apple's share price was $214.33. This rating comes amidst a notable development in Apple's performance in China, a key market for the company.
Apple has achieved an 8% year-over-year increase in iPhone sales in China during the second quarter of 2025. This marks the first quarterly growth in the region since 2023. The growth is largely due to promotional pricing strategies for the iPhone 16 lineup, particularly the Pro and Pro Max models. These strategies were well-timed with the 618 shopping festival, a major discount event in China.
Despite this positive development, Apple's growth in China was outpaced by Huawei, a major competitor, which reported a 12% increase in sales. This highlights the competitive nature of the Chinese smartphone market. Apple's strategic price adjustments, including increased trade-in values, played a crucial role in boosting sales during this period.
The resurgence in iPhone sales is a significant milestone for Apple as it seeks to solidify its presence in China, one of its most vital markets. The company's market capitalization stands at approximately $3.2 trillion, reflecting its substantial influence in the tech industry. As of the latest trading day, Apple's stock price increased by approximately 0.90% to $214.36, with a trading volume of 23.8 million shares.
Apple's stock has fluctuated between a low of $211.81 and a high of $214.64 during the trading day. Over the past year, the stock has reached a high of $260.10 and a low of $169.21. These figures indicate the volatility and potential for growth in Apple's stock, making UBS's Neutral rating a cautious yet reasonable stance for investors.

Mizuho Slashes Leslie’s Price Target to $1, Shares Drops 4%
2025-07-03 15:47:00
Mizuho lowered its price target on Leslie's (NASDAQ:LESL) to $1 from $3 while maintaining a Neutral rating, citing persistent top-line headwinds and deteriorating margins that have prompted downward revisions to earnings forecasts. As a result, the company’s shares fell over 4% intra-day today.
The analysts reduced Leslie’s 2025 adjusted EBITDA estimate to $98 million from $108 million, aligning it closer to company guidance of $96–$116 million. For 2026, the estimate was cut sharply to $122 million from $167 million, reflecting heightened concerns about the company’s ability to regain momentum.
Given Leslie’s elevated leverage of around 6x net debt/EBITDA at the end of Q2, Mizuho switched its valuation methodology from an EPS-based multiple to EV/EBITDA, setting the new $1 price target at around 8x 2026 adjusted EBITDA. This multiple mirrors forward valuations seen among struggling retail peers such as Target, Albertsons, and Best Buy.
Mizuho’s cautious stance reflects skepticism over Leslie’s ability to navigate current challenges, warning that prolonged sales and margin pressures could weigh heavily on both earnings and balance sheet flexibility.

Bernstein Raises Warner Music Target to $34 Ahead of Q3 Results
2025-07-03 15:44:00
Bernstein SocGen Group lifted its price target on Warner Music Group (NASDAQ:WMG) to $34 from $32 while maintaining an Outperform rating, anticipating in-line Q3 results but emphasizing the importance of new details that could shape expectations for fiscal 2026 earnings growth.
The analysts expect Warner’s upcoming Q3 report in early August to largely meet both its own and consensus estimates, but highlighted a potential earnings wildcard tied to cash proceeds from a recent legal settlement with Frontier, which could provide an unexpected boost to adjusted OIBDA and net income.
Looking beyond the quarter, Bernstein’s focus is on incremental disclosures that will clarify Warner’s growth trajectory for 2026, including: the timing of minimum per-subscriber escalators in new licensing deals with major streaming platforms like Spotify and Amazon Music; the pace of cost reductions, which this time should drop to the bottom line instead of being reinvested in artist development; and the timeline for deploying the $1.2 billion earmarked for catalog acquisitions through its joint venture with Bain Capital.
The analysts see these updates as critical to solidifying the bullish case for Warner shares, underpinned by expanding margins and strategic investments that could accelerate earnings growth into fiscal 2026.

RBC Lifts Celanese Price Target, Cautious on Near-Term Auto Weakness Despite Improved 2025 Outlook
2025-07-03 15:38:00
RBC Capital raised its price target on Celanese (NYSE:CE) to $63 from $53 while maintaining a Sector Perform rating, pointing to an improved outlook for fiscal 2025 but cautioning that persistent weakness in automotive builds could weigh on near-term results.
The analysts emphasized that Celanese’s Q2 performance will be key to gauging its success in managing inventories and positioning for stronger growth in the second half of the year. RBC is holding its estimates steady, projecting EPS of $1.33 for Q2, $4.97 for 2025, and $7.10 for 2026, along with EBITDA forecasts of $510 million, $1.975 billion, and $2.20 billion, respectively—figures that already factor in a recovery from Q1 lows.
However, the firm remains skeptical that Celanese can sustainably achieve its target of $2 EPS per quarter until it demonstrates meaningful volume improvements over the next few quarters. RBC’s updated price target reflects a modestly brighter medium-term outlook while acknowledging lingering headwinds that could limit near-term upside.

UBS Reiterates Buy on ExxonMobil, Sees Strong Q2 Despite Oil Price Headwinds
2025-07-03 15:35:00
UBS reiterated its Buy rating and $130 price target on Exxon Mobil (NYSE:XOM) forecasting Q2 2025 adjusted EPS of $1.66—comfortably ahead of the Street’s $1.52 consensus—while highlighting continued strong operational performance despite commodity price pressures.
The analysts project adjusted upstream net income of $5.16 billion, down $1.59 billion quarter-over-quarter but still above consensus of $4.71 billion. Expected total production volumes of 4.57 million barrels of oil equivalent per day (mmboepd) are in line with Street estimates.
UBS noted the primary driver of sequential earnings decline will be lower oil and gas prices, with Brent crude falling around $8 per barrel expected to create a $1.3 billion headwind to upstream earnings. Additionally, lower natural gas prices—Henry Hub declining ~$0.20/mmbtu and TTF ~$2.50/mmbtu—are seen contributing another ~$160 million drag. UBS also flagged the absence of approximately $100 million in favorable divestment-related earnings that boosted the prior quarter.
Despite these near-term challenges, the firm remains positive on ExxonMobil’s operational execution and maintains its bullish outlook, expecting the company to continue delivering resilient performance through market cycles.

UBS Trims C.H. Robinson Price Target to $129, Sees Near-Term Pressure
2025-07-03 15:32:00
UBS lowered its price target on C.H. Robinson Worldwide (NASDAQ:CHRW) to $129 from $130 while maintaining a Buy rating, as the firm reduced its Q2 2025 EPS forecast to $1.15 from $1.20 due to weaker-than-expected performance in the company’s forwarding segment.
The analysts cited reductions in forwarding gross revenue and operating margin assumptions, which drove a downward revision in forwarding EBIT from $40 million to $33 million. The updated EPS estimate of $1.15 sits below the current consensus of $1.18, with UBS expecting Street estimates to drift lower as models are updated for softer ocean freight activity during the quarter.
Despite the near-term headwinds, UBS remains constructive on C.H. Robinson’s shares, citing improving operational execution and the potential for a cyclical recovery in the truckload market, which could drive earnings upside over the longer term.

Needham Upgrades Meta to Hold, Cites Estimate Upside but Flags Valuation and Structural Risks
2025-07-03 15:30:00
Needham upgraded Meta Platforms (NASDAQ:META) to Hold from Underperform, citing recent channel checks that point to potential upside in its estimates and highlighting Meta’s exceptional labor productivity driven by its highly scalable, software-only economic model.
The firm noted Meta’s unique advantages—including not paying for content, leveraging mobile device ecosystems, and offering closed-loop attribution for advertisers—which together enable industry-leading efficiency. However, Needham stopped short of a Buy rating, remaining cautious due to several concerns: Meta’s sprawling strategy could dilute focus and waste capital; structural pressures on margins and free cash flow; high stock-based compensation per employee, which could lead to understated labor costs and dilution; and significant ongoing regulatory risks.
Needham also pointed to investor sentiment, observing that roughly 90% of analysts covering Meta have Buy or Strong Buy ratings, suggesting to the firm that the stock is likely over-owned and limiting further upside. The upgrade reflects acknowledgment of Meta’s near-term estimate strength, but the Hold rating signals skepticism about sustained long-term outperformance given these headwinds.

Kratos Defense & Security Solutions (NASDAQ:KTOS) Sees Positive Analyst Ratings and Price Targets
2025-07-03 15:03:54
Kratos Defense & Security Solutions (NASDAQ:KTOS) is a prominent player in the defense sector, specializing in unmanned systems and propulsion technology. The company is known for its innovative solutions that cater to both national security and commercial markets. Kratos competes with other defense giants, leveraging its advanced technology to maintain a competitive edge.
On July 3, 2025, Jonathan Siegmann from Stifel Nicolaus set a price target of $54 for KTOS, suggesting a potential upside of about 21.16% from its then trading price of $44.57. This optimistic outlook is supported by recent developments, as highlighted by Goldman Sachs, which upgraded KTOS to a "Buy" rating from a "Neutral" stance. This upgrade reflects growing confidence in Kratos' capabilities and market position. Goldman Sachs has set a new price target of $52 per share for KTOS, indicating an approximate 13% increase from its recent closing price of $45.84. This aligns with the positive sentiment surrounding the stock, which is currently priced at $44.64, marking a 3.14% increase or $1.36.
The stock's daily fluctuation between $43.65 and $44.81 shows investor interest and market activity. KTOS has experienced significant price movements over the past year, with a high of $47.09 and a low of $17.91. This volatility reflects the dynamic nature of the defense sector and investor sentiment. The company's market capitalization stands at approximately $6.85 billion, indicating its substantial presence in the industry. Today's trading volume for KTOS is 1,027,313 shares, demonstrating active investor engagement. As Kratos continues to innovate and expand its offerings, the stock's performance and analyst ratings suggest a promising outlook for the company in the defense market.